Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer

February 3, 2017

Carl A. K. Borrebaeck. Nature Reviews Cancer (2017) doi:10.1038/nrc.2016.153. Published online 03 February 2017

Click to read article

Home Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer